Compounds > fullerene c60
Page last updated: 2024-09-03

fullerene c60 and quinacrine

fullerene c60 has been researched along with quinacrine in 1 studies

Compound Research Comparison

Studies
(fullerene c60)		Trials
(fullerene c60)		Recent Studies (post-2010)
(fullerene c60)		Studies
(quinacrine)		Trials
(quinacrine)		Recent Studies (post-2010) (quinacrine)
3,80652,1704,05165289

Protein Interaction Comparison

ProteinTaxonomyfullerene c60 (IC50)quinacrine (IC50)
cystic fibrosis transmembrane conductance regulatorHomo sapiens (human)19.88
Major prion proteinMus musculus (house mouse)0.0951
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)2.896
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.964
Muscarinic acetylcholine receptor M4Homo sapiens (human)1.983
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)4.5
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)4.5
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)4.5
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)4.5
Muscarinic acetylcholine receptor M5Homo sapiens (human)3.736
Alpha-2A adrenergic receptorHomo sapiens (human)2.28
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)4.5
Muscarinic acetylcholine receptor M1Homo sapiens (human)1.489
Alpha-2B adrenergic receptorHomo sapiens (human)1.825
Alpha-2C adrenergic receptorHomo sapiens (human)3.857
Muscarinic acetylcholine receptor M3Homo sapiens (human)1.255
AcetylcholinesteraseHomo sapiens (human)2.667
Sodium-dependent noradrenaline transporter Homo sapiens (human)2.896
Histamine H2 receptorHomo sapiens (human)3.535
Alpha-1D adrenergic receptorHomo sapiens (human)2.065
5-hydroxytryptamine receptor 2AHomo sapiens (human)2.663
D(3) dopamine receptorHomo sapiens (human)1.318
Aldehyde oxidase 1Oryctolagus cuniculus (rabbit)10
CholinesteraseEquus caballus (horse)4.5
Aldehyde oxidaseHomo sapiens (human)3.3
Cyclic GMP-AMP synthaseHomo sapiens (human)7

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, S; Kobayashi, S; Matsubayashi, K; Mori, T; Namiki, M; Sawaguchi, T; Suzuki, T1

Other Studies

1 other study(ies) available for fullerene c60 and quinacrine

ArticleYear
Involvement of free radicals followed by the activation of phospholipase A2 in the mechanism that underlies the combined effects of methamphetamine and morphine on subacute toxicity or lethality in mice: comparison of the therapeutic potential of fulleren
    Toxicology, 2007, Jul-17, Volume: 236, Issue:3

    Topics: Animals; Body Temperature; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Enzyme Activation; Enzyme Inhibitors; Free Radical Scavengers; Free Radicals; Fullerenes; Heart; Hypothermia, Induced; Illicit Drugs; Kidney; Liver; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Morphine; Myocardium; Phospholipases A; Phospholipases A2; Quinacrine

2007